Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CRHBP | P24387 | 1/20 | 0.51 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.51 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18381730 | 1.00 | KMT2A (0.60) | KMT2AMEN1LMNAGAAKDM4E | |
| SCHEMBL18381729 | 1.00 | KMT2A (0.60) | KMT2AMEN1LMNAGAAKDM4E | |
| SCHEMBL29425354 | 1.00 | KMT2A (0.60) | KMT2AMEN1LMNAGAAKDM4E | |
| SCHEMBL28645163 | 0.86 | GAA (0.55) | KMT2AMEN1LMNAGAAKDM4E | |
| SCHEMBL2222145 | 0.86 | GAA (0.55) | KMT2AMEN1LMNAGAAKDM4E | |
| SCHEMBL29024339 | 0.85 | KDM4E (0.51) | KMT2AMEN1LMNAGAAKDM4E | |
| SCHEMBL2288515 | 0.85 | KMT2A (0.56) | KMT2AMEN1GAAKCNQ2 | |
| SCHEMBL23027214 | 0.85 | GAA (0.62) | KMT2AMEN1LMNAGAAKDM4E | |
| SCHEMBL805646 | 0.85 | GAA (0.62) | KMT2AMEN1LMNAGAAKDM4E | |
| SCHEMBL260296 | 0.85 | GAA (0.62) | KMT2AMEN1LMNAGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109804479-B | Hot carrier solar cell and method of forming the same | 南洋理工大学 | 2023-05-30 | — | — | CN | claimed |
| EP-3984075-A1 | OPTOELECTRONIC DEVICE | Oxford University Innovation Limited (GB) | 2022-04-20 | — | — | EP | claimed |
| CN-113278604-A | Method for hydrolyzing and splitting 2-phenylbutyric acid enantiomer by using immobilized lipase as catalyst | 湖南理工学院 | 2021-08-20 | — | — | CN | claimed |
| US-10845328-B2 | Nanoporous semiconductor thin films | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2020-11-24 | — | — | US | claimed |
| CN-109928868-A | The synthetic method and its application of bis- (2,5- 3,5-dimethylphenyl) the propyl- 2- ketone of 1,3- | 河北科技大学 | 2019-06-25 | — | — | CN | claimed |
| CN-108752510-A | Without iron catalysis AGET ATRP systems and polymerization under the conditions of ligand in a kind of biomass-based solvent | 安徽工程大学 | 2018-11-06 | — | — | CN | claimed |
| US-20180052136-A1 | NANOPOROUS SEMICONDUCTOR THIN FILMS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2018-02-22 | — | — | US | claimed |
| CN-107438424-A | Reduction of CPC taste aversion by reducing CPC activation of TRPA1 receptor, TPRV1 receptor, or both | 宝洁公司 | 2017-12-05 | — | — | CN | claimed |
| CN-104851979-B | A kind of fullerene phenylbutyric acid methyl ester derivation electron acceptor material formula | 厦门大学 | 2017-11-07 | — | — | CN | claimed |
| CN-105985241-A | Inhibition effect of [alpha]-substituted phenyl acetate compounds on [alpha]-glycosidase and application of the compounds | 邵阳学院 | 2016-10-05 | — | — | CN | claimed |
| US-20120112627-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND LIGHT EMITTING POLYMER COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-10 | — | — | US | claimed |
| CN-102276487-A | Preparation method of trimebutine | YUEYANG YETOP FINE CHEMICAL CO LTD | 2011-12-14 | — | — | CN | claimed |
| US-20110118217-A1 | Agonists for Antimicrobial Peptide Systems | AKTHELIA PHARMACEUTICALS (IS) | 2011-05-19 | — | — | US | claimed |
| CN-101959429-A | Agonists of antimicrobial peptide systems | AKTHELIA PHARMACEUTICALS | 2011-01-26 | — | — | CN | claimed |
| EP-2237684-A2 | AGONISTS FOR ANTIMICROBIAL PEPTIDE SYSTEMS | Akthelia Pharmaceuticals (IS) | 2010-10-13 | — | — | EP | claimed |
| CN-100544055-C | A kind of preparation method of novel mutual-leakage type polymer solar battery | UNIV JILIN (CN) | 2009-09-23 | — | — | CN | claimed |
| WO-2009087474-A2 | AGONISTS FOR ANTIMICROBIAL PEPTIDE SYSTEMS | AKTHELIA PHARMACEUTICALS (IS) | 2009-07-16 | — | — | WO | claimed |
| EP-1490469-A2 | METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS | North Carolina State University (US) | 2004-12-29 | — | — | EP | claimed |
| US-20030213747-A1 | Methods and compositions for removing residues and substances from substrates using environmentally friendly solvents | NORTH CAROLINA STATE UNIVERSITY | 2003-11-20 | — | — | US | claimed |
| WO-2003072215-A2 | METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS | NORTH CAROLINA STATE UNIVERSITY (US) | 2003-09-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118217-A1 | Agonists for Antimicrobial Peptide Systems | VIP, GLP1R, MAVS | KMT2A 4643/4885MEN1 3042/4885LMNA 4038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.